Journal Watch

« Back to Most Recent

  • Urgent Start PD + Diabetes

    A retrospective study compared the first 30-day outcomes and survival trends of 80 urgent start dialysis patients, 50 of whom (62.5%) did PD. Compared to those who started standard in-center HD, the dialysis-related complications were significantly lower for those on PD, and PD survival was higher as well. Read the abstract.

    Read the abstract » | (added 2018-10-12)

    Tags: Diabetes, Survival Trends, Urgent Start Dialysis, PD, In center HD, Dialysis related Complications

  • Albumin Predicts Survival in Anuric PD Patients

    Patients who don’t make urine have a better chance of survival on PD if their serum albumin levels are 3.6 g/dL or higher, finds a new study of 505 PD patients in Korea. Age, diabetes, ultrafiltration volume, and serum creatinine levels were other factors.

    Read the abstract » | (added 2018-05-11)

    Tags: Survival Predictors, Peritoneal Dialysis

  • Colonoscopy Antibiotic Protocols in PD

    A study comparing 46 PD patients who received prophylactic antibiotics prior to colonoscopy to 47 patients who did not found no difference in the risk of peritonitis between groups, even when polyps were removed during the procedure. Patients with diabetes did benefit from antibiotics, however. Read the abstract.

    Read the abstract » | (added 2017-11-13)

    Tags: Peritoneal Dialysis, Prophylactic Antibiotics, Colonoscopy

  • Magnesium and Vascular Calcification in PD

    In vitro and in animals, serum magnesium inhibits vascular calcification. In a study of 80 people on PD, X-ray studies of the spine found that the lower the serum magnesium levels, the higher the rate of calcification in the blood vessels. Adjusting for age, serum phosphate, serum PTH, cholesterol levels, smoking history, and diabetes did not change the results.

    Read the abstract » | (added 2017-04-12)

    Tags: Https://www.ncbi.nlm.nih.gov/pubmed/28385153

  • Heart Disease? PD is a Good Option

    In a single clinic study, 112 new patients starting PD with or without heart disease were followed for 5 years. More people with heart disease had diabetes (53.3% vs. 31.7%), and they tended to be older. But, there were no differences between groups in hospital admissions, peritonitis, or PD technique failure.

    Read the abstract » | (added 2017-02-08)

    Tags: Peritoneal dialysis

  • Glucose in PD Solution Affects Non-Diabetic Patients, Too

    Among 640 PD patients from three countries studied for up to 6.4 years, serum glucose levels rose with age and with higher dialysate glucose. In 5.4% of the sample, the levels suggested undiagnosed diabetes.

    Read the abstract » | (added 2016-06-08)

    Tags:

  • Glycated Albumin More Accurate in PD than Glycated Hemoglobin

    Using hemoglobin A1c levels to assess glycemic control in people with diabetes using PD is risky, because anemia causes false negative results. In a 6-month study, 20 people with diabetes using HD were matched for age, sex, and post-meal glucose levels with people with diabetes using PD. In a multiple regression analysis, glycated albumin was the only independent predictor of plasma glucose levels.

    Read the abstract » | (added 2016-05-12)

    Tags: Hemodialysis

  • Some PD Patients at Risk for New Onset Diabetes

    Among 612 people who did not have diabetes, 32 were diagnosed with the disease after starting PD. The risk of new diabetes was higher in those who were older, had higher BMIs, and whose blood had more markers of inflammation.

    Read the abstract » | (added 2016-02-09)

    Tags:

  • Why Do People Stop Doing Home HD?

    Among 2,840 people who started home HD between 2007 and 2009, nearly one in four stopped within a year, while 1-year mortality was 7.6%. The risks of stopping home HD were higher among those with diabetes, and substance use (alcohol, tobacco, drugs). Those who were listed for transplant or lived in rural areas were less likely to stop home HD.

    Read the abstract » | (added 2016-01-10)

    Tags: Hemodialysis

  • Liraglutide Has Multiple Benefits in People with Diabetes on PD

    In a small study, injectable liraglutide was tested in 16 people with type 2 diabetes who use PD, 11 of whom were previously on insulin, while three used oral medications and two controlled their blood sugar using diet alone. After 12 months, glucose fluctuations were reduced, post-meal blood sugars were lower, systolic blood pressure dropped—and left ventricular mass decreased (on echocardiogram).

    Read the abstract » | (added 2015-12-10)

    Tags: